Impact of pharmacologic treatment for alcohol use disorder on mortality in patients with alcohol-associated liver disease: analysis from a United States insurance claims database

Alcohol and Alcoholism 2026

View at publisher
Authors: Elizabeth Harris, Naina FNU, Christian N. Rhudy, Anthony A. Mangino, Tejas Joshi, Heba Yusuf, Christina Delacruz Leyson
DOI: 10.1093/alcalc/agag007
Cited by: 0
References: 11

Abstract

The aim of this retrospective cohort study was to evaluate the association of alcohol use disorder (AUD) treatment medications with clinical outcomes in alcohol-associated liver disease (ALD) using a nationwide commercial insurance claims and Medicare supplemental database. We found that patients who received a prescription for a medication to treat AUD after a hospital encounter for ALD had reduced mortality.

Fields of Study & Subjects

Substance Abuse Treatment and Outcomes Alcohol Consumption and Health Effects Alcoholism and Thiamine Deficiency

Publication details

Journal / source
Alcohol and Alcoholism
Volume
61
Issue
2
Publication date
14 January 2026
Language
EN